US Stock Market Move | Medtronic Plc (MDT.US) rose 4% in pre-market trading, with second-quarter performance exceeding expectations.

On Tuesday, Medtronic Plc (MDT.US) rose 4% in pre-market trading to $100.14. Medtronic Plc announced that its non-GAAP earnings per share for the second quarter of fiscal 2026 were $1.36, higher than the $1.26 reported a year ago, while analysts surveyed by FactSet had predicted $1.31. Net sales for the quarter ending on October 24 were $8.96 billion, up from $8.4 billion in the same period last year, surpassing the FactSet analyst estimate of $8.87 billion. For fiscal 2026, Medtronic Plc currently expects non-GAAP earnings per share to be between $5.62 and $5.66, compared to the previous guidance of $5.60 to $5.66. FactSet analysts had forecasted $5.62. The company stated that the new profit guidance includes a potential tariff impact of approximately $185 million. Medtronic Plc also raised its revenue growth forecast for fiscal 2026 from 5% to 5.5%.